| 标题 |
Phase 1 study of HP518, a PROTAC AR degrader in patients with mCRPC: results on safety, pharmacokinetics, and anti-tumor activity |
| 网址 | |
| DOI | |
| 其它 |
期刊:Investigational New Drugs 作者:Arun Azad; Howard Gurney; Craig Underhill; Lisa G. Horvath; Mark Voskoboynik; et al 出版日期:2025-04-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)